EcoDrugPlus

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPNAG00000020379
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSPNAG00000022719
Gene Symbol: LOC108440581
3 Cross references
249 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSPNAG00000016149
Gene Symbol: AHR
3 Cross references
154 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSPNAG00000027637
Gene Symbol: LOC108435512
3 Cross references
193 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSPNAG00000002552
Gene Symbol: LOC108431899
3 Cross references
205 Possible Orthologues:

Aurora Kinase C-Like

Ensembl ID : ENSPNAG00000023312
Gene Symbol: LOC108436926
3 Cross references
233 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSPNAG00000018285
Gene Symbol: LOC108431787
3 Cross references
192 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPNAG00000008182
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSPNAG00000008218
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPNAG00000000780
Gene Symbol: BDKRB2
4 Cross references
287 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPNAG00000026130
Gene Symbol: BDKRB2
1 Cross references
155 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSPNAG00000001582
Gene Symbol: LOC108414961
2 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).